Health data giant QuintilesIMS has changed its name to IQVIA. From November 15th, shares will trade on the NYSE under the new name and new ticker symbol 'IQV'.
QuintilesIMS was formed last year following the merger of IMS Health and healthcare consultancy Quintiles, a deal which valued the combined company at $17.6bn. This merger created one of the world's largest portfolios of healthcare information, therapeutic, domain, regulatory and commercial analytic expertise, as well as proprietary technology applications.
The company's client solutions are powered by what will now be known as the IQVIA CORE, giving clients access to its healthcare information source, advanced analytics, technologies and industry knowledge across diseases, geographies and scientific methods. Chairman and CEO Ari Bousbib (pictured) comments: 'Since the merger, we've worked to integrate our capabilities in advanced analytics, leading technologies and therapeutic expertise into powerful, differentiated offerings. Our vision is to outpace the inevitable progress of change across the life sciences and accelerate our ability to empower healthcare decision makers to meet the future head on'.
Web site: www.iqvia.com .